Philip Morris, the international tobacco giant, is acquiring the Israeli company Syqe Medical in a deal that could reach $650 million, Calcalist has learned. Syqe’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis. The deal consists of several milestones. Philip Morris will initially invest $120 million to support the process
Philip Morris, the international tobacco giant, is acquiring the Israeli company Syqe Medical in a deal that could reach $650 million, Calcalist has learned. Syqe’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis. The deal consists of several milestones. Philip Morris will initially invest $120 million to support the process […]
Cannabis Law Report
You must log in to post a comment.